Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Cuts NorthView Note Conversion Floor to $0.20 From $1.07

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.53
Mkt Cap
$323.597K
52W Low
$0.51
52W High
$1,593.754
52W Position info
3.9% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PFSA is trading near its 52-week low of $0.51 (3.9% above the low) on light trading volume (0.1× avg).

Summary

Profusa lowered the conversion floor on its NorthView note from $1.07 to $0.20, making conversion into stock far cheaper for the holder and increasing potential dilution.


Key Events · Financing and Capital Events · PFSA

  • Conversion Floor Slashed to $0.20

    Amendment No. 4 sets the NorthView note conversion price at the higher of $0.20 or the prior day's close, replacing the $1.07 floor.

  • Dilution Mechanics Unchanged at 122%

    Conversion shares equal principal times 122% divided by the conversion price, so a lower price yields more shares per dollar converted.

  • Note Principal Up to $2.5M

    The underlying note was issued in an original principal amount of up to $2,500,000 and remains outstanding.

  • Board and Audit Committee Approved

    The Fourth Amendment was approved by the Audit Committee and the Board of Directors, effective November 5, 2026.


Analysis · PFSA · Industrial Applications And Services

Profusa amended its NorthView Sponsor note so the conversion price is now the higher of $0.20 or the prior day's close, down from a $1.07 floor. With the stock at $0.53, the old floor was far above market and effectively blocked conversion; the new floor sits below the current price, so the holder can convert into shares at a much lower effective cost. Because conversion shares are principal times 122% divided by the conversion price, each dollar of principal now converts into more stock. This is a debt-for-equity lever that relieves the balance sheet but shifts value to the holder and dilutes existing shareholders, against a backdrop of going-concern doubt and a prior 49.9% insider stake.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $323.6K. The 52-week trading range was $0.51 to $1,593.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 13, 2026, 3:55 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.44199
Real-time Price: $0.3242 info
Change: -$0.11779 (-27%) info
Market Cap: $1.838M info
PFSA
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7158
Real-time Price: $0.3242 info
Change: -$0.3916 (-55%) info
Market Cap: $1.838M info
PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.3242 info
Change: -$0.1961 (-38%) info
Market Cap: $1.838M info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.3242 info
Change: -$0.9358 (-74%) info
Market Cap: $1.838M info
PFSA
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $0.3242 info
Change: -$1.09 (-77%) info
Market Cap: $1.838M info